人类的血栓生成,出血和静血:关于文学范围审查的协议
Joseph R Shaw1,2, Tyler James1,2, Jonathan Douxfils3
1Department of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Canada.
PloS one
|November 1, 2023
概括
血生成试验 (TGA) 提供了关于出血和静血的见解. 本综述综合了TGA的应用,方法和血液疾病的临床相关性,确定了知识差距和采用障碍.
科学领域:
- 血液学 血液学 血液学
- 凝血科学 凝血科学
- 临床检测 临床检测
背景情况:
- 血液静止和出血障碍会给测量带来一些挑战.
- 血栓生成试验 (TGA) 评估了前凝和抗凝因素.
- 对于TGA在出血障碍中的临床实用性需要进一步阐明.
研究的目的:
- 对TGA在研究出血和静血症中的应用进行范围审查.
- 综合有关TGA方法及其与出血结果相关的信息.
- 识别临床研究和实践中TGA采用的知识差距和障碍.
主要方法:
- 在MEDLINE,EMBASE和CENTRAL数据库中进行全面的文献搜索.
- 包括随机对照试验,非随机研究,系统审查和病例系列.
- 定性数据分析以映射和呈现发现.
主要成果:
- 综合当前TGA在血液静止和出血研究中的应用.
- 使用的各种TGA方法的概述.
- 证据总结,将TGA参数与临床出血和静血结局联系起来.
结论:
- TGAs显示出研究出血障碍的潜力,但临床意义仍然不确定.
- 需要进一步的研究来界定TGA作为临床相关的测试的适用性.
- 解决知识差距和采用障碍对于TGA的临床整合至关重要.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
Disorders of Hemostasis
957
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
957
Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Introduction to Hemostasis
8.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.1K
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Coagulation
6.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.9K


